 | Up a level |
Lubomirov, Rubin; di Iulio, Julia; Fayet, Aurélie; Colombo, Sara; Martinez, Raquel; Marzolini, Catia; Furrer, Hansjakob; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Ledergerber, Bruno; Rentsch, Katharina; Descombes, Patrick; Buclin, Thierry; Decosterd, Laurent A; Csajka, Chantal; Telenti, Amalio; Swiss HIV Cohort Study, (2010). ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenetics and genomics, 20(4), pp. 217-30. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e328336eee4
Pimenoff, V.N.; Laval, G.; Comas, D.; Palo, J.U.; Gut, I.; Cann, H.; Excoffier, L.; Sajantila, A. (2012). Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates. Pharmacogenetics and genomics, 22(12), pp. 846-857. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e32835a3a6d
Arnedo, M; Taffé, P; Sahli, R; Furrer, H; Hirschel, B; Elzi, L; Weber, R; Vernazza, P; Bernasconi, E; Darioli, R; Bergmann, S; Beckmann, JS; Telenti, A; Tarr, PE; Swiss, HIV Cohort Study (2007). Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and genomics, 17(9), pp. 755-64. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e32814db8b7
Colombo, S; Soranzo, N; Rotger, M; Sprenger, R; Bleiber, G; Furrer, H; Buclin, T; Goldstein, D; Décosterd, L; Telenti, A; Swiss, HIV Cohort Study (2005). Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo. Pharmacogenetics and genomics, 15(9), pp. 599-608. London: Lippincott Williams & Wilkins 10.1097/01.fpc.0000172241.42546.d3
Rotger, M; Colombo, S; Furrer, H; Bleiber, G; Buclin, T; Lee, BL; Keiser, O; Biollaz, J; Décosterd, L; Telenti, A; Swiss, HIV Cohort Study (2005). Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenetics and genomics, 15(1), pp. 1-5. London: Lippincott Williams & Wilkins
Sim, Sarah C; Miller, Walter L; Zhong, Xiao-Bo; Arlt, Wiebke; Ogata, Tsutomu; Ding, Xinxin; Wolf, C Roland; Flück, Christa E; Pandey, Amit V; Henderson, Colin J; Porter, Todd D; Daly, Ann K; Nebert, Daniel W; Ingelman-Sundberg, Magnus (2009). Nomenclature for alleles of the cytochrome P450 oxidoreductase gene. Pharmacogenetics and genomics, 19(7), pp. 565-6. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e32832af5b7
di Iulio, Julia; Fayet, Aurélie; Arab-Alameddine, Mona; Rotger, Margalida; Lubomirov, Rubin; Cavassini, Matthias; Furrer, Hansjakob; Günthard, Huldrych F; Colombo, Sara; Csajka, Chantal; Eap, Chin B; Decosterd, Laurent A; Telenti, Amalio (2009). In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenetics and genomics, 19(4), pp. 300-9. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e328328d577
Gong, Li; Stamer, Ulrike; Tzvetkov, Mladen V; Altman, Russ B; Klein, Teri E (2014). PharmGKB summary: tramadol pathway. Pharmacogenetics and genomics, 24(7), pp. 374-380. Lippincott Williams & Wilkins 10.1097/FPC.0000000000000057
Liakoni, Evangelia; Tyndale, Rachel F; Jacob, Peyton; Dempsey, Delia A; Addo, Newton; Benowitz, Neal L (2021). Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance. Pharmacogenetics and genomics, 31(5), pp. 97-107. Lippincott Williams & Wilkins 10.1097/FPC.0000000000000427
Eloranta, Jyrki J; Wenger, Christa; Mwinyi, Jessica; Hiller, Christian; Gubler, Christoph; Vavricka, Stephan R; Fried, Michael; Kullak-Ublick, Gerd A; Swiss IBD Cohort Study Group, The (2011). Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenetics and genomics, 21(9), pp. 559-64. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e328348f70c
Costa-Scharplatz, Madlaina; van Asselt, Antoinette D I; Bachmann, Lucas M; Kessels, Alfons G H; Severens, Johan L (2007). Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor. Pharmacogenetics and genomics, 17(5), pp. 359-368. London: Lippincott Williams & Wilkins 10.1097/01.fpc.0000236336.34175.e8
Lubomirov, Rubin; Arab-Alameddine, Mona; Rotger, Margalida; Fayet-Mello, Aurélie; Martinez, Raquel; Guidi, Monia; di Iulio, Julia; Cavassini, Matthias; Günthard, Huldrych F.; Furrer, Hansjakob; Marzolini, Catia; Bernasconi, Enos; Calmy, Alexandra; Buclin, Thierry; Decosterd, Laurent A.; Csajka, Chantal; Telenti, Amalio (2013). Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals. Pharmacogenetics and genomics, 23(1), pp. 9-18. Lippincott Williams & Wilkins 10.1097/FPC.0b013e32835ade82
Suenaga, Mitsukuni; Cao, Shu; Zhang, Wu; Matsusaka, Satoshi; Okazaki, Satoshi; Berger, Martin D.; Miyamoto, Yuji; Schirripa, Marta; Barzi, Afsaneh; Yamamoto, Noriko; Yamaguchi, Toshiharu; Lenz, Heinz-Josef (2021). Role of enterocyte-specific gene polymorphisms in response to adjuvant treatment for stage III colorectal cancer. Pharmacogenetics and genomics, 31(1), pp. 10-16. Lippincott Williams & Wilkins 10.1097/FPC.0000000000000416
